Atypical femur fracture in a male without history of bisphosphonate use: a case report

被引:0
|
作者
Al-Ajlouni, Yazan A. [1 ]
Lee, Justin Lin [1 ]
Lee, Jessica Lin [1 ]
Samuels, Blossom [1 ,2 ]
机构
[1] New York Med Coll, Sch Med, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY 10595 USA
关键词
Atypical femur fractures; Bisphosphonate-naive; Male; Teriparatide; Surgical management; FEMORAL FRACTURES; TERIPARATIDE; RISK;
D O I
10.1186/s13256-023-04308-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAtypical femur fractures are a rare occurrence, especially in bisphosphonate-naive men, and merit reporting owing to their unusual presentation and clinical implications. This case report highlights a unique instance of atypical femur fractures in a 73-year-old male with no prior bisphosphonate exposure.Case presentationThe patient, a 73-year-old Indian male with no history of bisphosphonate use, presented with left thigh pain and swelling following a minor fall. Radiographic assessment unveiled a closed left mid diaphyseal femoral shaft fracture. Subsequent imaging revealed an impending fracture in the contralateral femur. A comprehensive diagnostic evaluation, encompassing radiographic analysis, laboratory tests, and clinical assessment confirmed the diagnosis. Surgical management via intramedullary nailing was pursued for both fractures. Notably, the patient's medical history was characterized by radiographic manifestations, the infrequent occurrence of atypical femur fractures in men, and associated risk factors. Treatment encompassed anabolic bone therapy employing teriparatide, alongside discontinuation of antiresorptive agents.ConclusionsThis case underscores the significance of considering atypical femur fractures in older individuals with limited trauma history. It accentuates the role of anabolic agents in the therapeutic regimen and contributes to the evolving understanding of atypical femur fractures. The report underscores the need for vigilant monitoring and tailored management strategies in similar cases, thereby enhancing clinical practice and patient care.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: A case report
    Bissonnette, Lyne
    April, Pierre-Marc
    Dumais, Rejean
    Boire, Gilles
    Roux, Sophie
    BONE, 2013, 56 (02) : 406 - 409
  • [22] AN UNEXPECTED CASE OF ATYPICAL FEMUR FRACTURE MISDIAGNOSED AS RADICULOPATHY AND HIP OSTEOARTHRITIS: A PATIENT TREATED WITH BISPHOSPHONATE
    Saral, Ilknur
    Durmus, Oguz
    Agirman, Mehmet
    Ormeci, Tugrul
    Cakar, Engin
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2015, 18 (02): : 176 - 178
  • [23] Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy
    K.D. Gu
    B. Ettinger
    C.D. Grimsrud
    J.C. Lo
    Osteoporosis International, 2021, 32 : 2119 - 2123
  • [24] Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report
    Jeremy Keng Meng Goh
    Joyce Suang Bee Koh
    Alvin Choong Meng Ng
    Meng Ai Png
    Tet Sen Howe
    Calcified Tissue International, 2022, 111 : 96 - 101
  • [25] Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report
    Goh, Jeremy Keng Meng
    Koh, Joyce Suang Bee
    Ng, Alvin Choong Meng
    Png, Meng Ai
    Sen Howe, Tet
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (01) : 96 - 101
  • [26] Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
    S. L. Greenspan
    K. Vujevich
    C. Britton
    A. Herradura
    G. Gruen
    I. Tarkin
    P. Siska
    B. Hamlin
    S. Perera
    Osteoporosis International, 2018, 29 : 501 - 506
  • [27] Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure
    Lo, J. C.
    Grimsrud, C. D.
    Ott, S. M.
    Chandra, M.
    Hui, R. L.
    Ettinger, B.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (12) : 2515 - 2520
  • [28] Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
    Greenspan, S. L.
    Vujevich, K.
    Britton, C.
    Herradura, A.
    Gruen, G.
    Tarkin, I.
    Siska, P.
    Hamlin, B.
    Perera, S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (02) : 501 - 506
  • [30] Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy
    Gu, K. D.
    Ettinger, B.
    Grimsrud, C. D.
    Lo, J. C.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (10) : 2119 - 2123